Abstract
Connexins have been known to be the protein building blocks of gap junctions and mediate cell–cell communication. In contrast to the conventional dogma, recent evidence suggests that in addition to forming gap junction channels, connexins possess gap junction-independent functions. One important gap junction-independent function for connexins is to serve as the major functional component for hemichannels, the un-apposed halves of gap junctions. Hemichannels, as independent functional units, play roles that are different from that of gap junctions in the cell. The other functions of connexins appear to be gap junction- and hemichannel-independent. Published studies implicate the latter functions of connexins in cell growth, differentiation, tumorigenicity, injury, and apoptosis, although the mechanistic aspects of these actions remain largely unknown. In this review, gap junction- and hemichannel-independent functions of connexins are summarized, and the molecular mechanisms underlying these connexin functions are speculated and discussed.
Keywords: Gap junction- and hemichannel-independent, Connexin, Cell proliferation, Tumorigenicity, Cell differentiation
1. Introduction
Gap junctions comprised of connexins form transmembrane channels connecting cytoplasms of adjacent cells, which allow ions, small metabolites, and second messengers to translocate from cell to cell (for review, see Refs. [1,2]). This type of intercellular communication is known to be essential for various physiological and pathophysiological functions, such as cell growth, proliferation and differentiation, tissue homeostasis, tumorigenicity, wound healing, etc. Up to now, approximately 20 types of connexin molecules have been reported in the mouse and human [3]. Connexin mutations have been identified to be related to several diseases, such as X-linked Charcot–Marie–Tooth disease, congenital deafness and skin disorders, and congenital cataracts caused by mutations in Cx32, Cx26, Cx46 and 50, respectively. More than 160 mutations of Cx32 have been found [4], some of which lead to complete loss of functional channels, while others form functional channels with certain abnormalities in channel behavior. Recently, several reports revealed other unconventional functions of connexins. In addition to being a component of gap junctions, connexin molecules can form hemichannels, which are un-apposed halves of the gap junction channels. The actions of connexins that form hemichannels have been discussed in detail elsewhere (for review, see Ref. [5]). In this review, we focus on the roles of connexins that are gap junction- and hemichannel-independent.
A study indicating that connexins may have separate, non-gap junction-related functions was reported in 1995 [6]. Since then, the molecular mechanism of this novel, significant type of action by connexins has started being investigated and elucidated. Increasing evidence suggests gap junction-independent function of connexins in cell growth and proliferation, tumorigenicity, differentiation, injury, and apoptosis.
2. Gap junction-independent functions of connexins on cell growth and tumorigenicity
It has long been known that gap junction intercellular communication (GJIC) contributes to the maintenance of normal cell growth and that the rate of cell growth is inversely correlated with the extent of GJIC [7,8]. Disruption of communication often results in abnormal cell growth and tumors. Therefore, the role of gap junctions and connexins is suggested in tumor suppression [9–11]. Additionally, aberrant connexins are most common in tumor tissues, such as the reduction in connexin expression and/or aberrant localization of connexin. Despite some of the arguments as to whether GJIC is involved in the control of cell growth, there is unequivocal evidence to show that connexins can suppress cell growth both in vitro and in vivo.
There is increasing evidence for gap junction-independent roles of connexins in the control of cell growth and the suppression of tumorigenicity (for summary, see Table 1). Mesnil et al. [6] observed that among cells transfected with various connexin genes, there was no correlation between their GJIC and tumorigenicity. GJIC levels were significantly higher in tumors induced by injecting cells transfected with Cx26 in nude mice although all of the connexin genes (Cx43, Cx40, and Cx26) examined could establish GJIC in HeLa cells. The report by Huang et al. [12] shows that transfection of the Cx43 gene into human glioblastoma cells reversed the transformed phenotype of these tumor cells; however, the tumor suppression by Cx43 was unrelated to the activity of GJIC determined by Lucifer Yellow dye coupling. Moreover, tumor-suppressive effect of connexins is more connexin species-specific than their activity in cell coupling [12,13]. Two reports from Yamasaki’s group further show that certain mutants of Cx26 and Cx43 exert dominant negative effects on cell growth and tumorigenicity, but such effects are independent of the actions on GJIC assessed by dye transfer of Lucifer Yellow [14,15]. In one study, three mutated Cx26 genes (C60F, P87L and R143W) were expressed in HeLa cells that contained the wild-type Cx26 gene, and were GJIC-competent and non-tumorigenic. Interestingly, mutants, Cx26-P87L and Cx26-R143W, enhanced the tumorigenicity of the HeLa Cx26 cells in nude mice without any changes in GJIC. On the other hand, expression of the Cx26-C60F mutant reduced the GJIC level without affecting their growth in vivo [14]. In another study, two Cx43 mutants (L160M and A253V) were used to examine dominant-negative effects of Cx43 mutants on cell growth control exerted by wild-type Cx43 in C6 cells [15]. The mutant Cx43-L160M diminished in vitro growth-suppressive functions and GJIC capacity of wild-type Cx43 while it showed only weak dominant-negative effects on in vivo tumor-suppressive function. In contrast, the mutant Cx43-A253V presented a strong dominant-negative effect on both in vitro cell growth and in vivo tumor suppression exerted by wild-type Cx43 but not on GJIC. In the communication-proficient rat bladder carcinoma BC31 cell line, dominant negative mutants derived from the third transmembrane domain, Cx43-K162A, Cx43-E166E, and Cx43-T154Y, all blocked cell coupling; but only Cx43-T154Y substantially accelerated cell growth in vivo [16]. Interestingly, only cells transfected with the Cx43-T154Y mutant exhibited plasma membrane localization and allowed the transfer of the smaller molecules like neurobiotin, but not bigger molecules like Lucifer Yellow. The study by Moorby and Patel [17] provide direct evidence suggesting that growth regulation by Cx43 is independent of gap junction formation. They show that there was no correlation between the action of Cx43 mutants (S255A, S279A, and S282) on cell growth and Lucifer Yellow dye coupling in 3T3 A31 fibroblasts and that blockade of gap junction formation by either heptan-1-01 or culturing cells at low density had no effect on the ability of the Cx43 mutants to control cell growth. Moreover, wild-type Cx43 inhibited growth of Neuro2a cells independent of gap junction formation and the C-terminus of Cx43 that could not form gap junctions was as effective as the wild-type in suppressing the growth of Neuro2a cells. The second extracellular loop mutants of Cx43 (F199L, R202 E, and E205R) in another study were shown to inhibit cell growth despite their inability to form functional gap junction channels [18]. All these data suggest that certain mutant connexins exert dominant negative effects on connexin-regulated growth and that such effects are independent of the ability of GJIC.
Table 1.
References | Cell Systems | Connexin types | GJIC-independent functions in cell/tumor growth | GJIC | Connexin localization |
---|---|---|---|---|---|
Mesnil et al. [6] | HeLa cells | Cx26, Cx40, Cx43 (transfected) | Cx26—cell growth inhibition; Cx 40 and Cx43—no effect | GJIC for all three connexins | Cx40, Cx43—cell–cell contact; Cx26—cytosol |
Huang et al. [12] | Human glioblastoma cells | Cx43 (transfected) | Inhibition on cell and tumor growth | No GJIC | Mainly in the nucleus and cytoplasm |
Duflot-Dancer et al. [14] | HeLa cells expressing Cx26 | Cx26 mutants: C60F, R87L, R143W (transfected) | P87L and R143W—increased tumorigenicity; C60F—no change | R87L and R143W—no change; C60F—reduced | Cell–cell contact area |
Omori and Yamsaki [15] | C6 glioma cells expressing Cx43 | Dominant negative Cx43 mutants: L160M and A253V | Both mutants inhibit the effect of wt Cx43 on suppression of tumor growth | A253V—no inhibition on GJIC; L160M—inhibition | No changes of distribution pattern |
Krutovskikh et al. [16] | Rat bladder carcinoma BC31 cell | Dominant negative Cx43 mutants: K162A, E166G and T154Y | None of the mutants had effects on cell growth; T154Y accelerated tumor growth. | All three mutants blocked GJIC; T154Y—only transfer of neurobiotin | Wt and T154Y in the lateral membrane; K162A and E166G in the cytoplasm. |
Moorby and Patel [17] | 3T3 A31 fibroblasts expressing endogenous Cx43 and Neuro2a cells with no endogenous connexins | Cx43 mutants: S255A, S279A, S282A, C-terminal truncated (1–256) and C-terminal domain | In 3T3 cells, S279A and S282A grew slowly; S255A faster than control; mutants affected cell growth without cell contact and GJ; In Neuro2a cells, wt Cx43 and Cx43 C-terminus, but not Cx43(1–256), suppressed cell growth without GJ. | Cells expressing S255A, S279A, and S282A mutants were coupled similarly and prevent PDGF-induced loss of cell coupling in 3T3 cells. | N/A |
Olbina and Eckhart [18] | HeLa and C6 glioma cells | Second extracellular mutants of Cx43: F199L, R202E, and E205R | Mutants had similar inhibition of cell growth as wt Cx43 | Loss of GJIC by mutants | Wt—plasma membrane; Mutants—membrane and cytoplasm |
Dang et al. [19] | Cardiomyocytes and HeLa cells | C-terminal domain of Cx43 | Inhibition of cell growth | N/A | Cytoplasm and nucleus |
Bond et al. [13] | C6 glioma cells | Cx32 (transfected) | Cell growth in vitro—no change; tumor growth—retarded | No correlation of the function with GJIC | N/A |
Qin et al. [20] | MDA-MB-231 | Cx43 and Cx26 (retroviral delivery) | Dramatic suppression of tumor growth | No substantial rescue of GJIC | Cytoplasm of cells and xenoplants |
Several studies show gap junction-dependent and -independent functions of connexins. Cx43 inhibited cardiomyocyte DNA synthesis irrespectively of cell–cell coupling; however, GJIC was required to reverse Cx43 inhibition of DNA synthesis by phosphorylation of Cx43 at S262, a phosphorylation site regulated by growth factor or protein kinase C [19]. In some cases, overexpression of connexins does not affect cell growth in vitro, but exerts the effect on tumor suppression. Bond et al. [13] found that Cx32-overexpressing C6 glioma cells did not have a reduced growth rate in vitro but that tumor growth was retarded in vivo; however, GJIC was shown to be highly up-regulated. Retroviral delivery of Cx43 and Cx26 genes to MDA-MB-231 cells failed to exhibit significant differences in in vitro cell growth, but resulted in a dramatic suppression of tumor growth [20]. In this study, GJIC determined by Lucifer Yellow dye transfer was not substantially rescued and most of the Cx43 expressed was in cytoplasmic stores with no detectable gap junctions.
One possible argument for the above observations of gap junction-independent role of connexins is that most GJIC activities are analyzed by using mainly a single type of dye, such as Lucifer Yellow, which may not accurately reflect the ability of an intracellular substance to pass through gap junctions. However, there are several lines of evidence against the argument. First, Cx43-transfected cells that show tumor suppression predominantly express the unphosphorylated form of Cx43 [12], suggesting a lack of gap junction assembly on the cell surface [21]. Second, the connexins, which have the effect on cell growth inhibition and tumor suppression, localize in the cytoplasm or nucleus [12,20], excluding the possible involvement of gap junctions and hemichannels. Third, only the C-terminal domain of Cx43 displays similar or even more growth suppression as the wild-type Cx43 [17,19] and the C-terminus of Cx43 mainly localizes to the cytosol and nucleus [17,19]. These studies suggest that the expression of connexins per se, but not the extent of GJIC, corresponds to in vitro or in vivo growth control and suppression.
3. Gap junction-independent functions of connexins on cell differentiation
Recently, we and others have suggested the gap junction-independent effect of connexins on cell differentiation. The studies by Le and Musil [22] show that the inhibition of intercellular coupling with the chemical reagent, 18β-glycyrrhetinic acid (β-GA), had no effect on lens cell differentiation. Since β-GA is a blocker for gap junctions and hemichannels, this study implies the involvement of a GJIC- and hemichannel-independent process. However, it is not clear whether the process of lens cell differentiation requires connexin expression at all. In contrast to this observation, an earlier report shows that the inhibition of GJIC by Rous sarcoma virus blocked lens cell differentiation [23]. In these inhibitory studies, general channel inhibitors of gap junctions and hemichannels are used instead of specific reagents; thus, it is difficult to evaluate the inhibitory effect on the activities of individual connexins. In our study, primary cultures of chick lens, which display the similar process as in vivo epithelial-fiber differentiation, were used to explore the roles of connexins in lens cell differentiation [24]. Of the three lens connexins (Cx43, Cx45.6 and Cx56) overexpressed in these cultures, only Cx45.6 stimulated lens cell differentiation, but the other two did not. Moreover, overexpression of Cx45.6 did not affect GJIC assessed by using two types of dye-transfer approaches and two different fluorescent dyes. Our study demonstrates a GJIC-independent effect of Cx45.6 on lens cell differentiation. In support of our observations, the expression levels of Cx45.6 orthologue also correspond to the degree of lens cell differentiation. Yang and Louis [25] show that in contrast to the level of Cx44, the ovine orthologue of Cx56, which remained low, the level of Cx49, the ovine orthologue of Cx45.6, was increased in association with the differentiation of lens primary culture. Recently, we show that the C-terminus of Cx45.6 is sufficient to promote lens cell differentiation to a similar extent as wild-type Cx45.6 [26]. This further reinforces the GJIC-independent role of Cx45.6 in lens cell differentiation.
4. Other GJIC-independent functions of connexins
Tumor cells expressing the herpes simplex virus type 1 thymidine kinase (HSV-tk) are killed by nucleoside analogues such as ganciclovir (GCV). GCV affects not only the cells expressing HSV-tk but also the neighboring cells that do not express the gene through a pathway known as the “bystander effect”. The “bystander effect” of tumor cells has been known to be mediated by GJIC. Cx43-mediated GJIC has been reported as a major mechanism for the transfer of GCV to neighboring cells [27–29]. Recently, a gap junction-independent mechanism has also been proposed. Human lung carcinoma cell lines [30], as well as a rat colon tumor line [31], exhibited a bystander effect that was not altered by gap junction inhibitors [30,31] or an enhancer [31]. However, these studies do not provide direct evidence if this process relies on the expression of connexins. Another report shows that a human colon tumor cell line was highly sensitive to HSV-TK/GCV bystander effect killing, even though these cells had both minimal gap junction dye transfer capability and diffuse Cx43 expression [32]. GCV metabolites have been suggested to be effluxed from cells and that some type of cellular uptake mechanism independent of gap junctions exists for nucleotide entry into neighboring cells [33]. However, the existence of connexins in these cells is not conclusive even though the expression of Cx43 is found to be minimal; the membrane components responsible for efflux/ uptake cycle of GCV metabolites are also unknown. Recently, connexin-forming hemichannels are reported, which facilitate the transport of charged small molecules, such as ATP, NAD+, and PGE2 [34–39]. The connexin-forming hemichannels may offer an alternative pathway for efflux/uptake of GCV metabolites.
A recent report shows that connexins mediate gap junction-independent resistance to astrocyte injury [40]. In this report, they found that connexin-expressing cells retained their resistance in cell cultures with few cell contacts. The expression of two connexin mutants that failed to establish functional GJIC efficiently protected the cells against injury. Moreover, pharmacological inhibition of gap junction channels using α-GA only insignificantly reduced the injury resistance of connexin-expressing cells. Although they did not directly examine the involvement of connexin-forming hemichannels, the fact that α-GA can block both gap junctions and hemichannels excludes the functional participation of hemichannels. Gene array analysis showed that 10 genes were regulated by both gap junction forming- and non-forming-Cx26, including the genes related to angiogenesis [41]. This study suggests that Cx26 regulates angiogenesis-related molecules by mechanisms that are both GJIC-dependent and -independent.
5. Molecular mechanism of gap junction- and hemichannel-independent actions of connexins
The mechanistic aspects of the gap junction- and hemi-channel-independent functions of connexins remain largely unknown. One of the important questions remains as to how connexin expression, in the absence of substantial increases in GJIC and hemichannels, induces a reduction in cell and tumor growth. Several possible mechanisms have been hypothesized. First, the carboxyl terminus of Cx43 can regulate cell growth, implying possible interactions with other proteins. Transcription factors are possible interactive candidates. The connexins that exhibit cell growth suppression function have been localized to the cytoplasm or nucleus [17,19]. Targeting of Cx43 to the nucleus is plausible, given the putative nuclear-targeting sequence encoded within the carboxyl terminus [17]. Indeed, overexpression of connexins appears to regulate gene expression. Overexpression of Cx43 or Cx26 in MDA-MB-231 cells resulted in down-regulation of fibroblast growth factor receptor (FGFR)-3, a member of the FGFR family consisting of potent angiogenic factors that promote tumor growth and invasion. [20]. Overexpression of Cx43 also suppressed the expression of milk fat globule epidermal growth factor 8 (MFG-E8) [42], a growth factor involved in cell anchorage and integrin signaling, and the expression of monocyte chemotactic protein, MCP-1 [43]. Second, the suppression of cell and tumor growth by connexins could be through the regulation of proteins responsible for cell cycle progression. Zhang et al. [44] have reported that overexpression of Cx43 is attributed to an accumulation of the hypophosphated retinoblastoma (Rb) protein and a marked increase in the level of cyclin-dependent kinase inhibitor p27, although the gap junction-dependent and the gap junction-independent mechanisms contributed to the increase of p27. This group also reported that Cx43 inhibited expression of S phase kinase-associated protein 2 (Skp2), the human F-box protein that regulates the ubiquitination of p27 [45]. This inhibition was independent of GJIC due to the fact that gap junction inhibitors did not affect the inhibitory effect and that the C-terminus domain that did not form the gap junction channels exhibited nearly the same inhibitory effects as that of the full-length Cx43 [46]. Both Skp2 and p27 were required for Cx43 to inhibit cell proliferation, in that Cx43 barely inhibited cell proliferation of the SKP2−/− and p27−/− cells [45]. They postulated that cAMP was involved in the gap junction-dependent pathway for p27 synthesis [44], and a gap junction-independent inhibition of Skp2 expression was responsible for the reduced p27 degradation [45,46]. They suggested that the gap junction-independent pathway contributed much more than the gap junction-dependent one in the Cx43-induced cell growth suppression by targeting the proto-oncogene SKP2 and consequently increasing the level of the cell cycle controller p27. The exact mechanism of Cx43 in regulation of Skp2 is yet to be determined.
Recent findings suggest that connexins interact with other proteins including tight junction proteins, ZO-1, occludin, claudins, N-cadherin, and the cytoskeletons, microtubules, actin, and catenins [49–54]. Cx43 and N-cadherin are suggested to modulate neural crest cell mobility, by engaging in a dynamic cross-talk through p120 catenin signaling [50]. β-Catenin signaling, which was down-regulated by overexpression of N-cadherin, was found to inhibit activation of another cyclin-dependent kinase inhibitor p21 gene expression. The inhibitory effect of N-cadherin was augmented by co-expression of Cx43; however, this effect appears to correlate with the activity of GJIC [47]. In fact, α-catenin, a cadherin-associated protein, is shown to trigger trafficking and assembly of Cx43 and Cx32 into gap junctions in androgen-independent human prostate cancer cell lines [48]. Cell–cell and cell–extracellular matrix interactions are likely to induce cell differentiation and other cellular functions through the interactions of connexins with other junctional and/or cytoskeletal proteins, which could be a GJIC-dependent or independent process.
6. Perspectives
Connexins appear to at least possess three types of functions. The first function is its well-accepted role in forming gap junction channels and allowing the transfer of small molecules between cells [2]. The second function is related to the newly identified role of connexin as a component in formation of hemichannels [5]. The third type of functions appears to be independent of gap junctions and hemichannels. The multiple functions of connexin may in part explain why vertebrates have so many types of connexins [55]. Undoubtedly, the differences in the tissue distribution, substrate selectivity, and gating properties of gap junctions and hemichannels result in unique functions for individual connexins [1,5]. However, there are considerable overlaps, especially the expression of more than one type of connexin in a single type of cell, such as lens fibers and hepatocytes, although the formation of heteromeric connexons has been observed [56,57]. The lack of homology between the cytoplasmic carboxyl termini of connexins suggests that the C-terminus is likely to be functionally involved in the gap junction- and hemichannel-independent function of connexins. Indeed, studies have shown that GJIC is independent of C-terminal domains [58,59]. The three-dimensional structures of gap junctions formed by wild-type and C-terminus truncated Cx43 are almost identical [60,61], further implying that the C-terminal tail may not be an essential structural component of gap junction channels. Unlike most of the structural proteins with slower turnover, connexins behave more or less like regulatory proteins with apparent half-lives around 1–3 h [1,2]. Together, all these evidences suggest novel gap junction-unrelated functions of connexins. Future work should be directed towards elucidating the molecular mechanism underlying the gap junction-independent roles of connexins in many aspects of cellular activities, such as cell growth and differentiation, cellular injury, and tumorigenicity.
Acknowledgments
The work was supported by grants from the National Institute of Health (EY12085 and AR46798) and the Welch Foundation (AQ-1507). We thank Dr. Priscilla P. Cherian and Arlene Siller-Jackson in Jiang’s laboratory for critical reading of the manuscript.
References
- 1.Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem. 1996;65:475–502. doi: 10.1146/annurev.bi.65.070196.002355. [DOI] [PubMed] [Google Scholar]
- 2.Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003;83:1359–1400. doi: 10.1152/physrev.00007.2003. [DOI] [PubMed] [Google Scholar]
- 3.Evans WH, Martin PE. Gap junctions: structure and function. Mol Membr Biol. 2002;19:121–136. doi: 10.1080/09687680210139839. [DOI] [PubMed] [Google Scholar]
- 4.Abrams CK, Oh S, Ri Y, Bargiello TA. Mutations in connexin32: the molecular and biophysical bases for the X-linked form of Charcot–Marie–Tooth disease. Brain Res Rev. 2000;32:203–214. doi: 10.1016/s0165-0173(99)00082-x. [DOI] [PubMed] [Google Scholar]
- 5.Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nature Rev. 2003;4:1–10. doi: 10.1038/nrm1072. [DOI] [PubMed] [Google Scholar]
- 6.Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K, Yamasaki H. Negative growth-control of HeLa-cells by connexin genes-connexin species-specificity. Cancer Res. 1995;55:629–639. [PubMed] [Google Scholar]
- 7.Mehta PP, Bertram JS, Loewenstein WR. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell. 1986;44:187–196. doi: 10.1016/0092-8674(86)90497-6. [DOI] [PubMed] [Google Scholar]
- 8.Loewenstein WR, Rose B. The cell–cell channel in the control of growth. Semin Cell Biol. 1992;3:59–79. doi: 10.1016/s1043-4682(10)80008-x. [DOI] [PubMed] [Google Scholar]
- 9.Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Zaidan-Dagli ML, Omori Y. Role of connexin (gap junction) genes in cell growth control and carcinogenesis, Comptes Rendus de l Academie des Sciences-Serie III. Sciences de la Vie -Life Sci. 1999;322:151–159. doi: 10.1016/s0764-4469(99)80038-9. [DOI] [PubMed] [Google Scholar]
- 10.Mesnil M. Connexins and cancer. Biol Cell. 2002;94:493–500. doi: 10.1016/s0248-4900(02)00025-4. [DOI] [PubMed] [Google Scholar]
- 11.Yamasaki H, Naus CCG. Role of connexin genes in growth control. Carcinogenesis (Lond) 1996;17:1199–1213. doi: 10.1093/carcin/17.6.1199. [DOI] [PubMed] [Google Scholar]
- 12.Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin43 (cx43) Cancer Res. 1998;58:5089–5096. [PubMed] [Google Scholar]
- 13.Bond SL, Bechberger JF, Khoo NKS, Naus CCG. Transfection of C6 glioma cells with connexin32: the effects of expression of a nonendogenous gap junction protein. Cell Growth Differ. 1994;5:179–186. [PubMed] [Google Scholar]
- 14.Duflot-Dancer A, Mesnil M, Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene. 1997;15:2151–2158. doi: 10.1038/sj.onc.1201393. [DOI] [PubMed] [Google Scholar]
- 15.Omori Y, Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int J Cancer. 1998;78:446–453. doi: 10.1002/(sici)1097-0215(19981109)78:4<446::aid-ijc10>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- 16.Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene. 2000;19:505–513. doi: 10.1038/sj.onc.1203340. [DOI] [PubMed] [Google Scholar]
- 17.Moorby C, Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp Cell Res. 2001;271:238–248. doi: 10.1006/excr.2001.5357. [DOI] [PubMed] [Google Scholar]
- 18.Olbina G, Eckhart W. Mutations in the second extracellular region of connexin 43 prevent localization to the plasma membrane, but do not affect its ability to suppress cell growth. Mole Cancer Res. 2003;1:690–700. [PubMed] [Google Scholar]
- 19.Dang XT, Doble BW, Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem. 2003;242:35–38. [PubMed] [Google Scholar]
- 20.Qin H, Shao Q, Gurtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem. 2002;277:29132–29138. doi: 10.1074/jbc.M200797200. [DOI] [PubMed] [Google Scholar]
- 21.Musil LS, Cunningham BA, Edelman GM, Goodenough DA. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and deficient cell lines. J Cell Biol. 1990;111:2077–2088. doi: 10.1083/jcb.111.5.2077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Le AN, Musil LS. Normal differentiation of cultured lens cells after inhibition of gap junction-mediated intercellular communication. Dev Biol. 1998;204:80–96. doi: 10.1006/dbio.1998.9030. [DOI] [PubMed] [Google Scholar]
- 23.Menko AS, Boettiger D. Inhibition of chicken embryo lens differentiation and lens junction formation in culture by pp60v-src. Mol Cell Biol. 1988;8:1414–1420. doi: 10.1128/mcb.8.4.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gu S, Yu XS, Yin X, Jiang JX. Stimulation of lens cell differentiation by gap junction protein connexin 45.6. Invest Ophthalmol Visual Sci. 2003;44:2103–2111. doi: 10.1167/iovs.02-1045. [DOI] [PubMed] [Google Scholar]
- 25.Yang DI, Louis CF. Molecular cloning of ovine connexin44 and temporal expression of gap junction proteins in a lens cell culture. Invest Ophthalmol Visual Sci. 2000;41:2658–2664. [PubMed] [Google Scholar]
- 26.Yu XS, Jiang JX. Stimulation of lens fiber differentiation by C-terminus of connexin 45.6. Mol Biol Cell. 2003;14:219a. [Google Scholar]
- 27.McMasters R, Jones KE, Saylors RL, Hendrix EM, Moyer MP, Drake RR. Lack of bystander killing in HSV-TK transduced colon cell lines due to deficient connexin 43 gap junction formation. Hum Gene Ther. 1998;9:2253–2261. doi: 10.1089/hum.1998.9.15-2253. [DOI] [PubMed] [Google Scholar]
- 28.Elshami AA, Saavedra A, Zhang H, Kucharczuk JC, Spray DC, Fishman GI, Amin KM, Kaiser LR, Albelda SM. Gap junctions play a role in the “bystander effect” of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 1996;3:85–92. [PubMed] [Google Scholar]
- 29.Yang L, Chiang Y, Lenz HJ, Danenberg KD, Spears CP, Gordon EM, Anderson WF, Parekh D. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ ganciclovir-based gene therapy of human gastrointestinal tumor cells. Hum Gene Ther. 1998;9:719–728. doi: 10.1089/hum.1998.9.5-719. [DOI] [PubMed] [Google Scholar]
- 30.Princen F, Robe P, Lechanteur C, Mesnil M, Jean-Michel R, Gielen J, Marie-Paule M, Bours V. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect. Clin Cancer Res. 1999;5:3639–3644. [PubMed] [Google Scholar]
- 31.Imaizumi K, Hasegawa Y, Kawabe T, Emi N, Saito H, Naruse K, Shimokata K. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines. Am J Respir Cell Mol Biol. 1998;18:205–212. doi: 10.1165/ajrcmb.18.2.2821. [DOI] [PubMed] [Google Scholar]
- 32.Boucher PD, Ruch RJ, Shewach DS. Differential ganciclovir mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. Hum Gene Ther. 1998;9:801–814. doi: 10.1089/hum.1998.9.6-801. [DOI] [PubMed] [Google Scholar]
- 33.Drake KD, Schuette D, Chepelinsky AB, Crabbe MJC. Heterologous expression and topography of the main intrinsic protein (MIP) from rat lens. FEBS Lett. 2002;512:191–198. doi: 10.1016/s0014-5793(02)02256-1. [DOI] [PubMed] [Google Scholar]
- 34.Stout CE, Costantin JL, Naus CCG, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem. 2002;277:10482–10488. doi: 10.1074/jbc.M109902200. [DOI] [PubMed] [Google Scholar]
- 35.Jorgensen NR, Henriksen Z, Sørensen OH, Eriksen EF, Civitelli R, Steinberg TH. Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. J Biol Chem. 2002;277:7574–7580. doi: 10.1074/jbc.M104608200. [DOI] [PubMed] [Google Scholar]
- 36.Guyot A, Hanrahan JW. ATP release from human airway epithelial cells studied using a capilary cell culture system. J Physiol. 2002;545:199–206. doi: 10.1113/jphysiol.2002.030148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Romanello M, D’Andrea P. Dual mechanism of intercellular communication in HOBIT osteoblastic cells: a role for gap-junctional hemichannels. J Bone Miner Res. 2001;16:1465–1476. doi: 10.1359/jbmr.2001.16.8.1465. [DOI] [PubMed] [Google Scholar]
- 38.Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemichannels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 2000;15:10–12. doi: 10.1096/fj.00-0566fje. [DOI] [PubMed] [Google Scholar]
- 39.Jiang JX, Cherian PP. Hemichannels formed by connexin 43 play an important role in the release of prostaglandin E2 by osteocytes in response to mechanical strain. Cell Adhes Commun. 2003;10:259–264. doi: 10.1080/cac.10.4-6.259.264. [DOI] [PubMed] [Google Scholar]
- 40.Lin JHC, Yang J, Liu SJ, Takano T, Wang XH, Gao Q, Willecke K, Nedergaard M. Connexin mediates gap junction-independent resistance to cellular injury. J Neurosci. 2003;23:430–441. doi: 10.1523/JNEUROSCI.23-02-00430.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Qin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, Laird DW. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Adhes Commun. 2003;10:387–393. doi: 10.1080/cac.10.4-6.387.393. [DOI] [PubMed] [Google Scholar]
- 42.Goldberg GS, Bechberger JF, Tajima Y, Merritt M, Omori Y, Gawinowicz MA, Narayanan R, Tan Y, Sanai Y, Yamasaki H, Naus CC, Tsuda H, Nicholson BJ. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res. 2000;60:6018–6026. [PubMed] [Google Scholar]
- 43.Huang R, Lin Y, Wang CC, Gano J, Lin B, Shi Q, Boynton A, Burke J, Huang RP. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. 2002;62:2806–2812. [PubMed] [Google Scholar]
- 44.Zhang YW, Morita I, Ikeda M, Ma KW, Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene. 2001;20:4138–4149. doi: 10.1038/sj.onc.1204563. [DOI] [PubMed] [Google Scholar]
- 45.Zhang YW, Nakayama K, Morita I. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2) Cancer Res. 2003;63:1623–1630. [PubMed] [Google Scholar]
- 46.Zhang YW, Kaneda M, Morita I. The gap junction-independent tumor suppressing effect of connexin 43. J Biol Chem. 2003 doi: 10.1074/jbc.M305072200. [DOI] [PubMed] [Google Scholar]
- 47.Kamei J, Toyofuku T, Hori M. Nagative regulation of p21 by beta-catenin-TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem Biophys Res Commun. 2003;312:380–387. doi: 10.1016/j.bbrc.2003.10.129. [DOI] [PubMed] [Google Scholar]
- 48.Govindarajan R, Zhao S, Song XH, Guo RJ, Wheelock M, Johnson KR, Mehta P. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by a-catenin. J Biol Chem. 2002;277:50087–50097. doi: 10.1074/jbc.M202652200. [DOI] [PubMed] [Google Scholar]
- 49.Giepmans BN, Verlann I, Hengeveld T, Janssen H, Calafat J, Falk MM, Moolenaar WH. Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol. 2001;11:1364–1368. doi: 10.1016/s0960-9822(01)00424-9. [DOI] [PubMed] [Google Scholar]
- 50.Xu X, Li WEI, Huang GY, Meyer R, Chen T, Luo Y, Thomas MP, Radice GL, Lo CW. Modulation of mouse neural crest cell mobility by N-cadherin and connexin 43 gap junctions. J Cell Biol. 2001;154:217–229. doi: 10.1083/jcb.200105047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wu JC, Tsai RY, Chung TH. Role of catenins in the development of gap junctions in rat cardiomyocytes. J Cell Biochem. 2003;88:823–835. doi: 10.1002/jcb.10390. [DOI] [PubMed] [Google Scholar]
- 52.Theiss C, Meller K. Microinjected anti-actin antibodies decrease gap junctional intercellular communication in cultured astrocytes. Exp Cell Res. 2002;281:197–204. doi: 10.1006/excr.2002.5652. [DOI] [PubMed] [Google Scholar]
- 53.Duffy HS, Delmar M, Spray DC. Formation of the gap junction nexus: binding partners for connexins. J Physiol (Paris) 2002;96:243–249. doi: 10.1016/s0928-4257(02)00012-8. [DOI] [PubMed] [Google Scholar]
- 54.El-Sabban ME, Abi-Mosleh LF, Talhouk RS. Developmental regulation of gap junctions and their role in mammary epithelial cell differentiation. J Mammary Gland Biol Neoplasia. 2003;8:463–473. doi: 10.1023/B:JOMG.0000017432.04930.76. [DOI] [PubMed] [Google Scholar]
- 55.Eiberger J, Degen J, Romualdi A, Deutsch U, Willecke K, Sohl G. Connexin genes in the mouse and human genome. Cell Adhes Commun. 2001;8:163–165. doi: 10.3109/15419060109080717. [DOI] [PubMed] [Google Scholar]
- 56.Jiang JX, Goodenough DA. Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci U S A. 1996;93:1287–1291. doi: 10.1073/pnas.93.3.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Stauffer KA. The gap junction proteins b1-connexin (connexin-32) and b2-connexin (connexin-26) can form heteromeric hemichannels. J Biol Chem. 1995;270:6768–6772. [PubMed] [Google Scholar]
- 58.Dunham B, Liu S, Taffet S, Trabka-Janik E, Delmar M, Petryshyn R, Zheng S, Perzova R, Vallano ML. Immunolocalization and expression of functional and nonfunctional cell-to-cell channels from wild-type and mutant rat heart connexin43 cDNA. Circ Res. 1992;70:1233–1243. doi: 10.1161/01.res.70.6.1233. [DOI] [PubMed] [Google Scholar]
- 59.Fishman G, Moreno AP, Spray DC, Leinwand LA. Functional analysis of human cardiac gap junction channel mutants. Proc Natl Acad Sci U S A. 1991;88:3525–3529. doi: 10.1073/pnas.88.9.3525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Unger VM, Kumar NM, Gilula NB, Yeager M. Three-dimensional structure of a recombinant gap junction membrane channel. Science. 1999;283:1176–1180. doi: 10.1126/science.283.5405.1176. [DOI] [PubMed] [Google Scholar]
- 61.Cheng A, Schweissinger D, Dawood F, Kumar N, Yeager M. Projection structure of full length connexin 43 by electron cryocrystallography. Cell Adhes Commun. 2003;10:187–191. doi: 10.1080/cac.10.4-6.187.191. [DOI] [PubMed] [Google Scholar]